Impurities of tazarotene: Isolation and structural characterisation

Journal of Pharmaceutical and Biomedical Analysis

Volumn 46, Issue 3, 2008, Pages 574-576

  Brenna, Elisabetta ^a   Frigoli, Samuele ^a   Fronza, Giovanni ^a   Fuganti, Claudio ^a   Serra, Stefano ^a  

^a CNR   (Italy)

Author keywords

Impurity; Isolation; Structural characterisation; Tazarotene

Indexed keywords

1,4 BIS(4,4 DIMETHYLTHIOCHROMAN 6 YL)BUTA 1,3 DIYNE; ETHYL 6 [(4,4 DIMETHYL 4H THIOCHROMEN 6 YL)ETHYNYL]NICOTINATE; NICOTINIC ACID DERIVATIVE; SULFOXIDE; TAZAROTENE; THIOCHROMAN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; COLUMN CHROMATOGRAPHY; DRUG IMPURITY; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PUMMERER REACTION; REDUCTION; SONOGASHIRA REACTION;

DRUG CONTAMINATION; MAGNETIC RESONANCE SPECTROSCOPY; NICOTINIC ACIDS;

EID: 37749047427     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.11.004     Document Type: Article

References (9)

1. R.A.S. Chandraratna, U.S. Patent 5,089,509 (1992).
2. R.A.S. Chandraratna, U.S. Patent 5,602,130 (1997).
3. Nagpal S., and Chandraratna R.A.S. Curr. Pharm. Design 6 (2000) 919-931
4. Frigoli S., Fuganti C., Malpezzi L., and Serra S. Org. Proc. Res. Dev. 9 (2005) 646-650
5. S. Frigoli, C. Fuganti, S. Serra, F. Pizzocaro, A. Bedeschi, P. Tubertini, Paolo, EP 1700855 (2006).
6. Horner K., and Liebigs J. Ann. Chem. 626 (1959) 19-24
7. Miller R.D., and McKean D.R. Tetrahedron Lett. 24 (1983) 2619-2622
8. Pathare D.B., Jadhav A.S., and Shingare M.S. Chromatographia 66 (2007) 247-250
9. Chinchilla R., and Nájera C. Chem. Rev. 107 (2007) 874-922